SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to its recent surge, driven by AI/Robotics sector sympathy and meme stock momentum, reminiscent of SMX's past performance. The community is actively discussing potential short squeezes and comparing it to similar plays, while also noting the company's small float and high short interest which are contributing to volatility.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid discussions about its financial performance and commentary surrounding the company's relationship with Donald Trump. Community members are debating the stock's valuation, revenue, and future prospects, while also sharing politically charged opinions. Recent news articles and Trump's social media activity are adding fuel to the ongoing conversation.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending due to concerns about its valuation relative to its growth prospects and the overall AI sector, with some community members pointing to a potential AI bubble and others defending the company's long-term potential. Discussions revolve around the recent stock decline, its relationship to Bitcoin's price movements, and contrasting views on the company's fundamentals after a period of high growth. Some traders are noting a heavy short presence.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid is trending as investors discuss its low free float and potential meme stock status, while others express frustration over the stock's recent performance despite positive developments like the Uber deal and increasing sightings of Lucid vehicles in Europe. Community members are focused on the search for a permanent CEO and potential partnerships to inject capital, drawing comparisons to Rivian's recent collaboration with VW as Lucid's stock price lags behind its competitors.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to promising trial data for its brain metastases imaging agent, sparking significant community discussion around its potential and market value. Some traders are eyeing technical indicators and potential short squeezes, while others express concern about volatility and potential pullbacks after a substantial premarket surge. The upcoming webinar is a key event that investors are watching for further insights and potential catalysts.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the stock approaches yearly highs, fueled by buzz around its autonomous Robotaxi testing and speculation on the company's AI advancements. Community discussions revolve around the potential for a continued rally, with some analysts setting ambitious price targets, while others caution about overvaluation and the reliance on future promises.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is trending amid discussions about its potential role in powering AI data centers, though some community members are expressing concern about the company's financial performance and stock dilution. News around government support and partnerships for small modular reactor (SMR) technology are also being actively monitored by investors. Overall, the conversation seems focused on whether NuScale can capitalize on the growing demand for reliable, carbon-free energy in the AI sector.

Freddie Mac engages in the provision of housing finance system solutions. It operates through the Single-Family and Multifamily segments. The Single-Family segment is involved in purchase, securitization, and guarantee of single-family loans, investments, and management of single-family mortgage credit risk and market risk. The Multifamily segment focuses on purchase, securitization, and guarantee of multifamily loans, investments, securities, and management of multifamily mortgage credit risk and market risk. The company was founded on July 24, 1970 and is headquartered in McLean, VA.

Federal Home Loan Mortgage Corp

Freddie Mac

FMCC is trending amid speculation about its future following comments regarding a potential IPO from a U.S. Commerce Secretary and anticipation surrounding upcoming announcements. Community members are actively discussing potential timelines, the structure of a deal that benefits current shareholders, and the potential impact of influential figures like Michael Burry and Bill Ackman. Investors are monitoring for developments that could reshape the mortgage GSE landscape, with some expressing long-term bullish sentiment.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as its stock price surges following its AI & Autonomy Day, where the company unveiled its new in-house AI chip and plans for autonomous driving features, leading to price target increases from analysts. Community discussions revolve around Rivian's potential to compete with Tesla in the EV and autonomous driving space, with some touting its LiDAR-based approach and vertical integration. Despite concerns about cash burn, the stock is experiencing a boost from positive sentiment surrounding its long-term prospects as a software and AI-defined vehicle company.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending downwards as investors discuss a potential unwind in AI infrastructure stocks, with some expressing concerns about the broader sector's valuation. Community members are debating whether to hold or sell amidst the volatility, while also speculating about potential news and the company's long-term prospects. The stock's price action has led to discussions about market manipulation and the influence of broader market trends, as well as the possibility of a significant upcoming announcement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>According to the topline data, patients experienced statistical gains in mobility and function.</li><li>All enrolled subjects remained free from ongoing immunotherapies at the last follow-up, and none needed rescue interventions.&nbsp;</li><li>Based on this data, Kyverna plans to submit a Biologics License Application to the U.S. Food and Drug Administration in the first half of 2026.</li></ul>Kyverna Therapeutics, Inc. (KYTX) shares drew significant investor attention on Monday morning after the company announced promising outcomes from its registrational Phase 2 study of the experimental CAR T-cell therapy mivocabtagene autoleucel (miv-cel) in patients with stiff person syndrome.Stiff person syndrome is a rare and disabling autoimmune condition with no approved treatments.<h2 class="st-heading-2">Positive Trial Outcomes</h2>In the KYSA-8 trial, a single infusion of miv-cel delivered sustained improvements in both primary and secondary disease measures. The 26 participants enrolled in the study were followed through the main analysis at 16 weeks, with additional observations continuing thereafter.According to the topline data, patients experienced statistical gains in mobility and function. For the primary timed 25-foot walk endpoint, median performance improved 46% compared with baseline, with 81% surpassing a clinically meaningful threshold.&nbsp;Following the trial outcome,&nbsp;<a href="https://stocktwits.com/symbol/KYTX">Kyverna’s stock</a> traded over 11% higher in Monday’s premarket. On Stocktwits, retail sentiment around the stock improved to ‘extremely bullish’ from ‘bullish’ territory the previous day. Message volume changed to ‘extremely high’ from ‘high’ levels in 24 hours.&nbsp;Secondary disability and stiffness indices also improved markedly. Among those who needed walking aids before therapy, two-thirds no longer required assistance by week 16.<h2 class="st-heading-2">Elimination Of Chronic Treatments</h2>All enrolled subjects remained free from ongoing immunotherapies at the last follow-up, and none needed rescue interventions.&nbsp;“Today’s topline data represent a significant breakthrough in the treatment of stiff person syndrome, demonstrating miv-cel’s ability to reverse progressive disability in a debilitating disease that has no approved therapies,” said Naji Gehchan, Chief Medical and Development Officer of Kyverna Therapeutics.&nbsp;Based on this data, Kyverna plans to submit a Biologics License Application to the U.S. Food and Drug Administration in the first half of 2026.KYTX shares have surged nearly 124% this year.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-goldman-sachs-downgrade-arm-holdings-stock/cLe4GDURE8v">Why Did Goldman Sachs Downgrade Arm Holdings Stock?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Senior Clinical Practice Facilitator Nicole Prescott administering breakthrough treatment to patient Katie Tinkler for lupus at University College London Hospital in London.

KYTX Stock Just Surged 11% Today – What Is The Connection With Stiff Person Syndrome?

In the KYSA-8 trial, a single infusion of miv-cel delivered sustained improvements across both primary and secondary measures of Stiff Person Syndrome.

Equity

In the KYSA-8 trial, a single infusion of miv-cel delivered sustained improvements across both primary and secondary measures of Stiff Person Syndrome.


Kyverna Therapeutics (NASDAQ:KYTX) Upgraded to Hold at Wall Street Zen

Wall Street Zen raised shares of Kyverna Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives Average Recommendation of "Moderate Buy" from Analysts

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five ratings firms that are presently covering the firm, MarketBeat reports...

William Blair Brokers Increase Earnings Estimates for KYTX

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) - Equities researchers at William Blair increased their FY2025 earnings estimates for Kyverna Therapeutics in a note issued to investors on...

FY2025 Earnings Forecast for KYTX Issued By Leerink Partnrs

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) - Analysts at Leerink Partnrs decreased their FY2025 EPS estimates for shares of Kyverna Therapeutics in a report issued on Wednesday, November...

Kyverna Therapeutics (NASDAQ:KYTX) Issues Quarterly Earnings Results, Beats Estimates By $0.12 EPS

Kyverna Therapeutics (NASDAQ:KYTX - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.85) earnings per share (EPS) for the quarter, beating the consensus...

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives Average Rating of "Moderate Buy" from Analysts

Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the five brokerages that are currently covering the stock, MarketBeat Ratings...

Kyverna Therapeutics (KYTX) Expected to Announce Quarterly Earnings on Wednesday

Kyverna Therapeutics (NASDAQ:KYTX) will be releasing its Q3 2025 earnings before the market opens on Wednesday, November 12. (View Earnings Report at...

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

KYTX
Kyverna Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KYTX News

KYTXKyverna Therapeutics Inc.